|
News for: |
|
You will land on a page at the National Library of Medicine where you can drill down to consumer info, research citations, product labelling, toxicology and more. FindingHealthOnline is the world's leading health-pharma search portal and decision engine. It helps you drill down to very detailed information without interference from commercial sites that now dominate Bing, Google, and Yahoo. Near the top of our pages, you will find a link to content that best matches your query.
|
|
|
FDA Approval Activities for this Drug…
Cylert Chewable Tablets (Pemoline), 18.75, 37.5 mg, and 75 mg Abbott NDA 16-832/ S-016 5/8/98 10/23/98 Cylert Chewable Tablets (Pemoline), 37.5 mg Abbott NDA 17-703/ S-014 5/13/98 10/23/98 Cylert Indication: Treatment of Attention Deficit Disorder Pemoline Tablets, 18.75 mg, 37.5 mg, and 75 mg, only Mallinckrodt, ANDA 75-726 3/30/01 4/2/01 Pemoline Chewable Tablets, 37.5 mg, Amide Pharmaceutical, ANDA 75-678 7/26/00 11/7/00 Pemoline Chewable Tablets, 37.5 mg, Copley Pharamceutical, ANDA 75-555 2/18/00 2/24/00 Pemoline Tablets, 18.75 mg, 37.5 mg & 75 mg., Amide Pharmaceutical, ANDA 75-595 2/28/00 2/29/00 Pemoline Tablets, 18.75 mg, 37.5 mg, 75 mg, Vintage ANDA 75-328 4/19/00 4/24/00 Pemoline Tablets, 37.5 mg & 75 mg., Watson ANDA 75-287 9/18/00 10/30/00 Pemoline Tablets, 37.5 mg & 75 mg. Invamed ANDA 75-286 6/30/99 7/2/99 Pemoline Tablets, 37.5 mg, and 75 mg, only Copley Pharmaceutical, ANDA 75-030 Cylert (pemoline) Tablets and Chewable Tablets, Abbott
|